Cardiac adverse events associated with chloroquine and hydroxychloroquine exposure in 20 years of drug safety surveillance reports
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cardiac adverse events associated with chloroquine and hydroxychloroquine exposure in 20 years of drug safety surveillance reports ; volume:10 ; number:1 ; day:5 ; month:11 ; year:2020 ; pages:1-8 ; date:12.2020
Scientific reports ; 10, Heft 1 (5.11.2020), 1-8, 12.2020
- Creator
-
Cohen, Isaac V.
Makunts, Tigran
Moumedjian, Talar
Issa, Masara A.
Abagyan, Ruben
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-020-76258-0
- URN
-
urn:nbn:de:101:1-2020121419021983954495
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cohen, Isaac V.
- Makunts, Tigran
- Moumedjian, Talar
- Issa, Masara A.
- Abagyan, Ruben
- SpringerLink (Online service)
Other Objects (12)
Cardiotoxicity of chloroquine and hydroxychloroquine through mitochondrial pathway
Chloroquine, hydroxychloroquine, and COVID-19, the Libyan prospective
The Ototoxicity of Chloroquine and Hydroxychloroquine: A Systematic Review
Hydroxychloroquine and chloroquine retinal safety concerns during COVID-19 outbreak
Lysosomotropic agents including azithromycin, chloroquine and hydroxychloroquine activate the integrated stress response
Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases
The parent drugs chloroquine and hydroxychloroquine do not inhibit human CYP3A activity in vitro
Hydroxychloroquine/chloroquine in patients with COVID-19 in Wuhan, China: a retrospective cohort study
Serious Cardiovascular Adverse Events Associated with Hydroxychloroquine/Chloroquine Alone or with Azithromycin in Patients with COVID-19: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS)
Translational Modeling of Chloroquine and Hydroxychloroquine Dosimetry in Human Airways for Treating Viral Respiratory Infections
Artificial intelligence for detection of retinal toxicity in chloroquine and hydroxychloroquine therapy using multifocal electroretinogram waveforms
Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China
Cardiotoxicity of chloroquine and hydroxychloroquine through mitochondrial pathway
Chloroquine, hydroxychloroquine, and COVID-19, the Libyan prospective
The Ototoxicity of Chloroquine and Hydroxychloroquine: A Systematic Review
Hydroxychloroquine and chloroquine retinal safety concerns during COVID-19 outbreak
Lysosomotropic agents including azithromycin, chloroquine and hydroxychloroquine activate the integrated stress response
Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases
The parent drugs chloroquine and hydroxychloroquine do not inhibit human CYP3A activity in vitro
Hydroxychloroquine/chloroquine in patients with COVID-19 in Wuhan, China: a retrospective cohort study
Serious Cardiovascular Adverse Events Associated with Hydroxychloroquine/Chloroquine Alone or with Azithromycin in Patients with COVID-19: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS)
Translational Modeling of Chloroquine and Hydroxychloroquine Dosimetry in Human Airways for Treating Viral Respiratory Infections
Artificial intelligence for detection of retinal toxicity in chloroquine and hydroxychloroquine therapy using multifocal electroretinogram waveforms
Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China
Cardiotoxicity of chloroquine and hydroxychloroquine through mitochondrial pathway
Chloroquine, hydroxychloroquine, and COVID-19, the Libyan prospective
The Ototoxicity of Chloroquine and Hydroxychloroquine: A Systematic Review
Hydroxychloroquine and chloroquine retinal safety concerns during COVID-19 outbreak
Lysosomotropic agents including azithromycin, chloroquine and hydroxychloroquine activate the integrated stress response
Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases
The parent drugs chloroquine and hydroxychloroquine do not inhibit human CYP3A activity in vitro
Hydroxychloroquine/chloroquine in patients with COVID-19 in Wuhan, China: a retrospective cohort study
Serious Cardiovascular Adverse Events Associated with Hydroxychloroquine/Chloroquine Alone or with Azithromycin in Patients with COVID-19: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS)
Translational Modeling of Chloroquine and Hydroxychloroquine Dosimetry in Human Airways for Treating Viral Respiratory Infections
Artificial intelligence for detection of retinal toxicity in chloroquine and hydroxychloroquine therapy using multifocal electroretinogram waveforms